<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boellaard WPA</submitter><funding>Erasmus MC</funding><funding>Dutch Cancer Society</funding><funding>KWF Kankerbestrijding</funding><funding>Erasmus Medisch Centrum</funding><pagination>463-468</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6767197</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The microRNA-371a-3p (miR-371a-3p) has been reported to be an informative liquid biopsy (serum and plasma) molecular biomarker for both diagnosis and follow-up of patients with a malignant (testicular) germ cell tumor ((T)GCT). It is expressed in all histological cancer elements, with the exception of mature teratoma. However, normal testis, semen, and serum of males with a disrupted testicular integrity without a TGCT may contain miR-371a-3p levels above threshold, of which the cellular origin is unknown.&lt;h4>Objectives&lt;/h4>Therefore, a series of relevant tissues (frozen and formalin-fixed paraffin-embedded (FFPE), when available) from the complete male urogenital tract (i.e., kidney to urethra and testis to urethra) and semen was investigated for miR-371a-3p levels usin</pubmed_abstract><journal>Andrology</journal><pubmed_title>Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation.</pubmed_title><pmcid>PMC6767197</pmcid><funding_grant_id>KWF 13‐6001</funding_grant_id><funding_grant_id>KWF 13-6001</funding_grant_id><pubmed_authors>Gillis AJM</pubmed_authors><pubmed_authors>Stoop H</pubmed_authors><pubmed_authors>Dorssers LCJ</pubmed_authors><pubmed_authors>Looijenga LHJ</pubmed_authors><pubmed_authors>Boellaard WPA</pubmed_authors><pubmed_authors>van Agthoven T</pubmed_authors><pubmed_authors>Boormans JL</pubmed_authors><pubmed_authors>Dinkelman-Smit M</pubmed_authors><pubmed_authors>van Leenders GJLH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation.</name><description>&lt;h4>Background&lt;/h4>The microRNA-371a-3p (miR-371a-3p) has been reported to be an informative liquid biopsy (serum and plasma) molecular biomarker for both diagnosis and follow-up of patients with a malignant (testicular) germ cell tumor ((T)GCT). It is expressed in all histological cancer elements, with the exception of mature teratoma. However, normal testis, semen, and serum of males with a disrupted testicular integrity without a TGCT may contain miR-371a-3p levels above threshold, of which the cellular origin is unknown.&lt;h4>Objectives&lt;/h4>Therefore, a series of relevant tissues (frozen and formalin-fixed paraffin-embedded (FFPE), when available) from the complete male urogenital tract (i.e., kidney to urethra and testis to urethra) and semen was investigated for miR-371a-3p levels usin</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2025-04-18T14:06:55.388Z</modification><creation>2019-10-11T07:13:08Z</creation></dates><accession>S-EPMC6767197</accession><cross_references><pubmed>30786164</pubmed><doi>10.1111/andr.12595</doi></cross_references></HashMap>